Imprimis Recall Unapproved Ophthalmic In
Imprimis NJOF recalled three intraocular ophthalmic injection drug products in December 2025 (as per USFDA
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
